Ambeed.cn

首页 / / / ERK / XMD8-92

XMD8-92 {[allProObj[0].p_purity_real_show]}

货号:A146338 Ambeed 开学季,买赠积分,赢豪礼

XMD8-92 is an inhibitor of ERK5/BMK1. The Kd values for BMK1, DCAMKL2, PLK4 and TNK1 are 80 nM, 190 nM, 600 nM and 890 nM respectively.

XMD8-92 化学结构 CAS号:1234480-50-2
XMD8-92 化学结构
CAS号:1234480-50-2
XMD8-92 3D分子结构
CAS号:1234480-50-2
XMD8-92 化学结构 CAS号:1234480-50-2
XMD8-92 3D分子结构 CAS号:1234480-50-2
规格 价格 会员价 库存 数量
{[ item.pr_size ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb_sale, 1,1) ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]}
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} 现货 咨询 - +
购物车0 收藏 询单

XMD8-92 纯度/质量文件 产品仅供科研

货号:A146338 标准纯度: {[allProObj[0].p_purity_real_show]}
批次查询: 批次纯度:

全球学术期刊中引用的产品

JACS Au, 2024. Ambeed. [ A148168 ]
JMC, 2024. Ambeed. [ A187643 ]
JMC, 2024. Ambeed. [ A341145 , A633512 , A607865 , A167774 ]
Biomacromolecules, 2024. Ambeed. [ A110759 ]
Biomacromolecules, 2024. Ambeed. [ A203543 ]
更多 >
产品名称 ERK ERK1 ERK2 ERK5 其他靶点 纯度
DEL-22379 +

ERK, IC50: 0.5 μM

+

ERK, IC50: 0.5 μM

{[allProObj[0].p_purity_real_show]}
Pluripotin ++

ERK1, Kd: 98 nM

RasGAP {[allProObj[0].p_purity_real_show]}
FR 180204 +

ERK1, Ki: 0.31 μM

++

ERK2, Ki: 0.14 μM

{[allProObj[0].p_purity_real_show]}
Ravoxertinib +++

ERK1, IC50: 1.1 nM

++++

ERK2, IC50: 0.3 nM

{[allProObj[0].p_purity_real_show]}
SCH772984 +++

ERK1, IC50: 4 nM

++++

ERK2, IC50: 1 nM

{[allProObj[0].p_purity_real_show]}
Temuterkib +++

ERK1, IC50: 5 nM

+++

ERK2, IC50: 5 nM

{[allProObj[0].p_purity_real_show]}
VX-11e +++

ERK2, Ki: <2 nM

{[allProObj[0].p_purity_real_show]}
Ulixertinib ++++

ERK2, IC50: <0.3 nM

{[allProObj[0].p_purity_real_show]}
XMD17-109 ++

ERK5, IC50: 162 nM

{[allProObj[0].p_purity_real_show]}
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。

XMD8-92 生物活性

靶点
  • BET

    BRD4 (1), Kd:170 nM

描述 BMK1 (Big MAP Kinase 1) is a member of the MAP kinase family. MAP kinases act as an integration point for multiple biochemical signals, and are involved in a wide variety of cellular processes such as proliferation, differentiation, transcription regulation and development. BMK1 is specifically activated by mitogen-activated protein kinase kinase 5 (MAP2K5/MEK5). It is involved in the downstream signaling processes of various receptor molecules including receptor type kinases, and G protein-coupled receptors. In response to extracelluar signals, this kinase translocates to cell nucleus, where it regulates gene expression by phosphorylating, and activating different transcription factors[3]. XMD8-92 is a BMK1 inhibitor. The dissociation constant (Kd) of XMD8-92 towards BMK1 was 80 nM, and data of XMD8-92 against other kinases suggested selectivity of XMD8-92 to BMK1. In a kinase activity assay utilizing Hela cell lysates, the IC50 of XMD8-92 against BMK1 was 1.5 μM. Furthermore, growth factor-induced activation of cellular BMK1 was effectively blocked by 1 μM XMD8-92, detected by mobility retardation. Cell proliferation assay revealed that 5 μM XMD8-92 inhibited more than 50% PC3, Hela and LL/2 cell growth when incubated for 48h[4]. 48h treatment of 25 μM XMD8-92 also inhibited cell proliferation of pancreatic tumor AsPC-1cells to the extent of more than 50%[5]. In animal experiments, treatment of mice bearing Hela or LL/2 xenografts with XMD8-92 at the dose of 50 mg/kg twice daily 1 day, several days, or weeks after inoculation of the tumor cells all significantly inhibit the growth of the tumors[4]. In an AsPC-1 xenograft model established in NOD/SCID mice, XMD8-92 administrated at the dose of 50 mg/kg i.p. daily for 15 days significantly inhibited tumor growth[5].
作用机制 XMD8-92 inhibits BMK1 via ATP site competition-binding. The selective binding and inhibition of XMD8-92 towards BMK1 was revealed by ATP-site competition binding assay and KiNativ method utilizing Hela cell lysates[4].

XMD8-92 细胞研究

细胞系 浓度 检测类型 检测时间 活动说明 数据源
human HeLa cells Function assay Inhibition of EGF-induced BMK1 autophosphorylation in human HeLa cells by SDS-PAGE analysis, IC50=0.24 μM 21412406

XMD8-92 参考文献

[1]Sureban SM, May R, et al. XMD8-92 inhibits pancreatic tumor xenograft growth via a DCLK1-dependent mechanism. Cancer Lett. 2014 Aug 28;351(1):151-61.

[2]Yang Q, Deng X, et al. Pharmacological inhibition of BMK1 suppresses tumor growth through promyelocytic leukemia protein. Cancer Cell. 2010 Sep 14;18(3):258-67.

[3]Kato Y, Tapping RI, Huang S, Watson MH, Ulevitch RJ, Lee JD. Bmk1/Erk5 is required for cell proliferation induced by epidermal growth factor. Nature. 1998 Oct 15;395(6703):713-6.

[4]Yang Q, Deng X, Lu B, Cameron M, Fearns C, Patricelli MP, Yates JR 3rd, Gray NS, Lee JD. Pharmacological inhibition of BMK1 suppresses tumor growth through promyelocytic leukemia protein. Cancer Cell. 2010 Sep 14;18(3):258-67.

[5]Sureban SM, May R, Weygant N, Qu D, Chandrakesan P, Bannerman-Menson E, Ali N, Pantazis P, Westphalen CB, Wang TC, Houchen CW. XMD8-92 inhibits pancreatic tumor xenograft growth via a DCLK1-dependent mechanism. Cancer Lett. 2014 Aug 28;351(1):151-61.

XMD8-92 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.11mL

0.42mL

0.21mL

10.54mL

2.11mL

1.05mL

21.07mL

4.21mL

2.11mL

XMD8-92 技术信息

CAS号1234480-50-2
分子式C26H30N6O3
分子量 474.555
别名
运输蓝冰
存储条件

粉末 Keep in dark place,Sealed in dry,2-8°C

液体 -20°C:3-6个月-80°C:12个月

溶解度

DMSO: 50 mg/mL(105.36 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

动物实验配方
Ambeed 相关网站 Ambeed.cn Ambeed.com
Ambeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
  • 客户支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    Ambeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务,不为任何个人或者非科研性质用途提供服务。